Allogene Therapeutics Inc
ALLO1.370USD
-0.100-6.80%
Market hours （ET）Quotes delayed by 15 min
305.73MMarket Cap
LossP/E TTM
Allogene Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
22.00K
-76.84%
EPS(YoY)
-1.32
36.59%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its total revenue reached 22.00K, with a year-on-year change of -76.84%.
What is the Earnings Per Share (EPS) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.322, with a year-on-year change of 36.59%.
What is the net income of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its net income was -257.59M, with a year-on-year change of 21.29%.
What is the net margin of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its net profit margin was -1170863.64%, with a year-on-year change of -239.88%.
What is the gross margin of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -55.13%, with a year-on-year change of 0.68%.
What is the Return on Assets (ROA) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -43.24%, with a year-on-year change of 3.27%.
What is the operating profit of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its operating profit was -257.48M, with a year-on-year change of 18.13%.
What are the current assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its current assets were 303.39M, with a year-on-year change of -33.92%.
What are the total assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its total assets of Allogene Therapeutics Inc were 548.71M, with a year-on-year change of -14.64%.
What are the total liabilities of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its total liabilities of Allogene Therapeutics Inc were 126.53M, with a year-on-year change of -3.12%.
What is the total equity of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its total equity of Allogene Therapeutics Inc was 422.18M, with a year-on-year change of -17.58%.
What is the net operating income of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its net operating income of Allogene Therapeutics Inc was -257.59M, with a year-on-year change of 21.29%.
What is the net investment of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its net investment of Allogene Therapeutics Inc was 75.69M, with a year-on-year change of -53.65%.
What is the net financing of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2024 earnings report, its net financing of Allogene Therapeutics Inc was 116.67M, with a year-on-year change of 21.92%.
